← All diseases
Cancer
Kidney cancer
Would you like to receive a message when there is new research about kidney cancer? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, a single sentence appears above each publication explaining what was investigated — and you receive a notification as soon as new research on Renal cell carcinoma is published. View what Premium costs.
Publications and studies (2186)
- Endoscopic resection of a late gastric metastasis from renal cell carcinoma presenting as a bleeding polyp. (2026/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Viniferin and its derivatives: a comprehensive review of structural variations and promising pharmacological applications in disease prevention and therapeutic development. (2026/03/01) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. The Effect of Taking Cabozantinib with a Light Breakfast: A Randomized Crossover Pharmacokinetic Study (SKIPPY 1). (2026/03/01) ♡
- Reassessing prognostic markers in metastatic renal cell carcinoma in the era of immune checkpoint inhibitors: the enduring value of body composition, nutritional, and inflammatory indices. (2026/03/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Geriatric prehabilitation prior to surgery for kidney tumors: Study protocol for Pre-KiT - A randomized controlled trial. (2026/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Therapeutic potential of cytokine-induced killer cell therapy for renal cell carcinoma and prostate cancer. (2026/02/28) ♡
- Why Does DNA Methylation Accumulate at CpG Loci?: Sequential Analysis of Cdkn2a/p16(Ink4a) Gene Methylation in a Rat Renal Tumor Model. (2026/02/27) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Nutrient intake and renal cancer: molecular pathways and mechanistic insights into the protective role of dietary components. (2026/02/26) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. The prognostic impact of systemic inflammation and nutritional indicators on targeted therapy for renal cell carcinoma: a systematic review and meta-analysis. (2026/02/25) ♡
- Circulating ERVFRD-1 and MFSD2A Are Associated with Immunotherapy Response in Metastatic Clear Cell Renal Cell Carcinoma. (2026/02/23) ♡
- [(18)F]AlF-RESCA-R8B4 and [(68)Ga]Ga-NOTA-R8B4: A Pair of Novel CD70-Targeted ImmunoPET/CT Imaging Agents for Clinical Use. (2026/02/20) ♡
- Comparative value of postoperative inflammatory indices in predicting recurrence in T3 stage renal cell carcinoma: superiority of the Cally index. (2026/02/17) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Electrochemical MicroRNA biosensors for kidney cancer: From biomarker discovery to point-of-care diagnostics. (2026/02/15) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Prognostic value of the prognostic nutritional index for patients with renal cell carcinoma: an update systematic review and meta-analysis. (2026/02/14) ♡
- The C-Reactive Protein-Albumin-Lymphocyte (CALLY) Index as an Independent Predictor of Progression and Survival in Metastatic Renal Cell Carcinoma. (2026/02/13) ♡
- Effect of the antifungal drug ciclopirox on the inhibition of HMGA2-mediated oncogenic capacity in ACHN renal cell carcinoma. (2026/02/13) ♡
- Multi-omics and machine learning framework reveals ABCG2 as a therapeutic target of Eleven Flavored Shenqi Tablets in clear cell renal cell carcinoma. (2026/02/10) ♡
- A novel biomarker SNHG11 promotes tumor progression and oxidative phosphorylation in clear cell renal cell carcinoma. (2026/02/02) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Attrition Rates in Metastatic Renal Cell Carcinoma (mRCC) Following First Line Immunotherapy-Based Treatment: Results From the International mRCC Database Consortium (IMDC). (2026/02/01) ♡
- Indeterminate Surgical Margins (Rx) in Renal Cell Carcinoma Surgery: Rates, Predictive Factors, and Impact on Overall Survival. (2026/02/01) ♡
- Non-Immunotherapy Arm Allocations in Phase 3 Genitourinary Cancer Trials with Immunotherapy. (2026/02/01) ♡
- (153)Sm-EDTMP Therapy as a Therapeutic Option in Mixed Skeletal Metastases from Renal Cell Carcinoma with Disease Progression Post 2nd Line Tyrosine Kinase Therapy. (2026/02/01) ♡
- JAK3 identified as a key toxicological target of aristolochic acid in clear cell renal cell carcinoma. (2026/02/01) ♡
- Assessment of Meet-URO and CANLPH Prognostic Models in Metastatic RCC: Insights from a Single-Institution Cohort Predominantly Treated with TKIs. (2026/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Tertiary lymphoid structures in renal cell carcinoma: from heterogeneity dissection to translational precision immunotherapy. (2026/01/29) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Roles of E3 ubiquitin ligases and deubiquitinating enzymes in renal cell carcinoma. (2026/01/21) ♡
- A multi-omics features-based approach integrating immunogenicity and inflammation enhances immunotherapy benefit in clear cell renal cell carcinoma. (2026/01/20) ♡
- Sialylation-immune-related lncRNA LINC01605 promotes tumor-infiltrating CD8(+) T cell exhaustion and malignancy of clear cell renal cell carcinoma. (2026/01/16) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Papillary renal neoplasm with reverse polarity and renal clear cell carcinoma: a case report of image-pathology-molecular multidimensional diagnosis and nephron sparing surgery practice. (2026/01/16) ♡
- Serine synthesis and transport mediate the synergistic and detoxifying effects of lienal peptides on cisplatin. (2026/01/16) ♡
- Multi-channel multiphase CT-based deep learning and radiomics fusion model for noninvasive pathological grading of clear cell renal cell carcinoma. (2026/01/15) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Surgical management of giant Xp11.2 translocation renal cell carcinoma with multivisceral invasion: a case report of en bloc resection and targeted-immunotherapy success. (2026/01/14) ♡
- Identification of IGF2BP3 and CENPA as key regulators of immunophenotypes in renal clear cell carcinoma. (2026/01/12) ♡
- Integrated multi-omic profiling reveals macrophage-driven prognostic signatures in clear cell renal cell carcinoma through machine learning optimization. (2026/01/12) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case Report: Analysis of colposcopic image features in a case of early-stage small cell neuroendocrine carcinoma of the cervix. (2026/01/12) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The fall of the genome protectors triad: PBRM1, SETD2, and BAP1's impact on metabolism and immunity in clear cell renal cell carcinoma. (2026/01/12) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. PANoptosis in urological diseases: molecular mechanisms, pathological roles, and emerging therapeutic opportunities. (2026/01/09) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case Report: A rare case of unilateral renal clear cell carcinoma with synchronous contralateral ureteral metastasis. (2026/01/09) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Clear cell renal carcinoma metastasis to the thyroid gland combined with papillary thyroid carcinoma - a case report. (2026/01/09) ♡
- Development of a novel prognostic model based on TRPM4-Induced sodium overload-mediated cell death in kidney cancer. (2026/01/09) ♡
- High salt-induced osmotic stress differentially modulates hepatocellular and renal carcinoma cell proliferation. (2026/01/09) ♡
- A robust ammonia metabolism gene signature identified by machine learning predicts prognosis and immunotherapy response in clear cell renal cell carcinoma. (2026/01/08) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Metabolic reprogramming in clear cell renal cell carcinoma: core pathways and targeted therapeutic strategies. (2026/01/05) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case report: Minimally invasive management of synchronous early-stage ascending colon adenocarcinoma and type 1 papillary renal cell carcinoma presenting with severe anemia: a rare Chinese case. (2026/01/05) ♡
- LINC01913 and LINC01389 as the novel diagnostic tumor markers for the early-stage renal cell carcinoma. (2026/01/01) ♡
- A nomogram based on contrast-enhanced computed tomography (CT)-derived extracellular volume fraction to predict disease-free survival in clear cell renal cell carcinoma postoperatively. (2026/01/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Improvement of Suspected Paraneoplastic Large-Vessel Vasculitis after Breast Cancer Resection: A Case Report. (2026/01/01) ♡
- Current controversies with active surveillance management of small renal masses. (2026/01/01) ♡
- Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors (2026-08-11) ♡
- Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Modulation of the Bone Immune Microenvironment Following Cabozantinib Treatment of Bone Metastatic Clear Cell Renal Cell Carcinoma: Proof of Concept Study (2026-08-11) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.